Systemic Lupus Erythematosus --Developing Medical Products for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 22, 2010
May 5, 2020
067dc730-0e77-42b9-a240-78f5dae2130b
Related Documents
Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims: Guidance for Industry
Guidance DocumentDecember 9, 2009Center for Drug Evaluation and Research
Drug-Induced Liver Injury: Premarketing Clinical Evaluation
Guidance DocumentJuly 29, 2009Center for Drug Evaluation and Research
Electronic Source Data in Clinical Investigations: Guidance for Industry
Guidance DocumentSeptember 18, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.